BioNTech profits soar in 2021 on global vaccine rollout
German vaccine-maker BioNTech on Wednesday reported a multi-billion-euro windfall in 2021 from sales of its anti-coronavirus jab, developed together with US pharmaceutical giant Pfizer.
Mar 30, 2022
0
8